Safety and Tolerability of LIM-0705 in Healthy Male Subjects

NCT01060475 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LIM-0705 and tacrolimus
DRUG: LIM-0705 and tacrolimus
DRUG: Placebo LIM-0705 and tacrolimus
DRUG: Drug LIM-0705 and placebo tacrolimus

Sponsor

Limerick BioPharma